The Leadership Team at SparingVision is responsible for guiding the company's strategic direction and ensuring alignment between its scientific, operational, and financial objectives. This team, comprised of key executives including the CEO, CMO, CTO, and CFO, collaborates to oversee the development of innovative therapies, drive fundraising efforts, and establish partnerships, all aimed at advancing treatments for blinding inherited retinal diseases like retinitis pigmentosa.